Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma

Cancer Letters

Volumn 261, Issue 2, 2008, Pages 235-243

  Pezzolo, Annalisa ^a   Capra, Valeria ^a   Raso, Alessandro ^a   Morandi, Fabio ^a   Parodi, Federica ^a   Gambini, Claudio ^a   Nozza, Paolo ^a   Giangaspero, Felice ^b   Cama, Armando ^a   Pistoia, Vito ^a   Garrè, Maria Luisa ^a  

^a G GASLINI INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CGH; Chromosomal imbalances; Ependymoma; FISH; Infant brain tumors

Indexed keywords

ARTICLE; CANCER SURVIVAL; CHROMOSOME 10Q; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; EPENDYMOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MALE; METAPHASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; COHORT STUDIES; CYTOGENETIC ANALYSIS; EPENDYMOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 39149145809     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.021     Document Type: Article

References (29)

1. Massimino M., Gandola L., Giangaspero F., et al. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 1336-1345
2. Wiestler O.D., Schiffer D., Coons S.W., et al. Ependymal tumors. In: Kleihues P., and Cavence W.K. (Eds). World Health Organization (WHO) Classification of Tumors: Pathology and Genetics of Tumors of the Nervous System (2000), IARC Press, Lyon 71-82
3. Teo C., Nakaji P., Symons P., et al. Ependymoma. Childs Nerv. Syst. 19 (2003) 270-285
4. Mork S.J., and Loken A.C. Ependymoma: a follow-up study of 101 cases. Cancer 40 (1997) 907-915
5. Merchant T.E. Current management of childhood ependymoma. Oncology (Huntingt) 16 (2002) 629-644
6. Pollack I.F., Gerszten P.C., Martinez A.J., et al. Intracranial ependymomas of childhood: long term outcome and prognostic factors. Neurosurgery 37 (1995) 655-666
7. Paulino A.C. Radiotherapeutic management of intracranial ependymoma. Pediatr. Hematol. Oncol. 19 (2002) 295-308
8. Robertson P.L., Zelrzer P.M., Boyett J.M., et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J. Neurosurg. 88 (1998) 695-703
9. Scheil S., Bruderlein S., Eicker M., et al. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol. 11 (2001) 133-143
10. Carter M., Nicholson J., Ross F., et al. Genetic abnormalities detected in ependymomas by comparative genomic hybridization. Br. J. Cancer 86 (2002) 929-939
11. Hirose Y., Aldape K., Bollen A., et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am. J. Pathol. 158 (2001) 1137-1143
12. Rickert C.H., and Paulus W. Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence. J. Neuropathol. Exp. Neurol. 63 (2004) 399-417
13. Reardon D.A., Entrekin R.E., Sublett J., et al. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 24 (1999) 230-237
14. Zheng P., Pang C., Hui A.B., et al. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. Cancer Genet. Cytogenet. 122 (2000) 18-25
15. Dyer S., Prebble E., Davison V., et al. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am. J. Pathol. 161 (2002) 2133-2141
16. Jeuken J.W., Sprenger S.H.E., Gilhuis J., et al. Correlation between localization, age, and chromosomal imbalances in ependymal tumors as detected by CGH. J. Pathol. 197 (2002) 238-244
17. Ward S., Harding B., Wilkins P., et al. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridization in pediatric ependymomas. Genes Chromosomes Cancer 32 (2001) 59-66
18. Grill J., Avet-Loiseau H., Lellouch-Tubiana A., et al. Cancer Genet. Cytogenet. 136 (2002) 121-125
19. Mendrzyk F., Korshunov A., Benner A., et al. Identification of gains on 1q and epidermal growth factor receptor over expression as independent prognostic markers in intracranial ependymoma. Clin. Cancer Res. 12 (2006) 2070-2079
20. Taylor M.D., Poppleton H., Fuller C., et al. Radial glial cells are candidate stem cells of ependymoma. Cancer Cell 8 (2005) 323-335
21. Modena P., Lualdi E., Facchinetti F., et al. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J. Clin. Oncol. 24 (2006) 5223-5233
22. Kallioniemi A., Kallioniemi O.P., Sudar D., et al. Comparative genomic hybridization for molecular cytogenetics analysis of solid tumors. Science 258 (1992) 818-821
23. Lucito R., Healy J., Alexander J., et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res. 13 (2003) 2291-2305
24. B. Gokart, J. Schmidtke, J.J. Cassiman, S. Aymé, Data storage and DNA banking for biomedical research: informed consent, confidentiality, qualità issue, ownership, return of benefits, A professional perspective, EUROGAPP PROJECT 1999-2000, ESHG, 2002.
25. Pezzolo A., Cinti R., Negri F., et al. Chromosomal imbalances in a novel pediatric case of Burkitt-like lymphoma and review of the literature in relation to other germinal center derived B-cell tumors. Leuk. Lymphoma 47 (2006) 2359-2364
26. Pan E., Pellarin M., Holmes E., et al. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin. Cancer Res. 11 (2005) 4733-4740
27. Tong C.Y., Hui A.B., Yin X.L., et al. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J. Neurosurg. 100 (2004) 187-193
28. De Bortoli M., Castellino R.C., Lu X.Y., et al. Medulloblastoma outcome is adversely associated with overexpression of EEFID, RPL30, and RPS20 on the long arm of chromosome 8. BMC Cancer 6 (2006) 223-236
29. Ammerlaan A.C.J., de Bustos C., Ararou A., et al. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray. Genes Chrom. Cancer 43 (2005) 329-338